Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated With Paclitaxel

Journal of Pain

Volumn 10, Issue 11, 2009, Pages 1146-1150

  Reyes Gibby, Cielito C ^a   Morrow, Phuong Khang ^a   Buzdar, Aman ^a   Shete, Sanjay ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

breast cancer; chemotherapy induced peripheral neuropathy; epidemiology; Neuropathic pain; survivors

Indexed keywords

PACLITAXEL;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; COMORBIDITY; DRUG INDUCED DISEASE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; PRESCRIPTION;

ANALGESICS; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; NEURALGIA; ODDS RATIO; PACLITAXEL; PATIENT ACCEPTANCE OF HEALTH CARE; PERIPHERAL NERVOUS SYSTEM DISEASES; RISK FACTORS;

EID: 70350570433     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2009.04.006     Document Type: Article

References (35)

1. Attal N., Cruccu G., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T., Sampaio C., Sindrup S., and Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
2. Buzdar A.U., Singletary S.E., Valero V., Booser D.J., Ibrahim N.K., Rahman Z., Theriault R.L., Walters R., Rivera E., Smith T.L., Holmes F.A., Hoy E., Frye D.K., Manuel N., Kau S.W., McNeese M.D., Strom E., Thomas E., Hunt K., Ames F., Berry D., and Hortobagyi G.N. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: Preliminary data of a prospective randomized trial. Clin Cancer Res 8 (2002) 1073-1079
3. Caraceni A., and Portenoy R.K. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82 (1999) 263-274
4. Cherny N.I. Opioid analgesics: Comparative features and prescribing guidelines. Drugs 51 (1996) 713-737
5. Cherny N.I., Thaler H.T., Friedlander-Klar H., Lapin J., Foley K.M., Houde R., and Portenoy R.K. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single-dose studies. Neurology 44 (1994) 857-861
6. Dennis S.G., and Melzack R. Self-mutilation after dorsal rhizotomy in rats: Effects of prior pain and pattern of root lesions. Exp Neurol 65 (1979) 412-421
7. Dray A., and Read S.J. Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther 9 (2007) 212
8. Flatters S.J., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
9. Flatters S.J., and Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 122 (2006) 245-257
10. Flatters S.J., Fox A.J., and Dickenson A.H. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res 984 (2003) 54-62
11. Green M.C., Buzdar A.U., Smith T., Ibrahim N.K., Valero V., Rosales M.F., Cristofanilli M., Booser D.J., Pusztai L., Rivera E., Theriault R.L., Carter C., Frye D., Hunt K.K., Symmans W.F., Strom E.A., Sahin A.A., Sikov W., and Hortobagyi G.N. Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol 23 (2005) 5983-5992
12. Grond S., Radbruch L., Meuser T., Sabatowski R., Loick G., and Lehmann K.A. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79 (1999) 15-20
13. Ivanavicius S.P., Ball A.D., Heapy C.G., Westwood F.R., Murray F., and Read S.J. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: Increased expression of ATF-3 and pharmacological characterisation. Pain 128 (2007) 272-282
14. Jacobson S.D., Loprinzi C.L., Sloan J.A., Wilke J.L., Novotny P.J., Okuno S.H., Jatoi A., and Moynihan T.J. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol 1 (2003) 274-278
15. Jin H.W., Flatters S.J., Xiao W.H., Mulhern H.L., and Bennett G.J. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: Effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 210 (2008) 229-237
16. Kannarkat G., Lasher E.E., and Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol 20 (2007) 719-725
17. Moulin D.E., Clark A.J., Gilron I., Ware M.A., Watson C.P., Sessle B.J., Coderre T., Morley-Forster P.K., Stinson J., Boulanger A., Peng P., Finley G.A., Taenzer P., Squire P., Dion D., Cholkan A., Gilani A., Gordon A., Henry J., Jovey R., Lynch M., Mailis-Gagnon A., Panju A., Rollman G.B., and Velly A. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12 (2007) 13-21
18. Naguib M., Diaz P., Xu J.J., struc-Diaz F., Craig S., Vivas-Mejia P., and Brown D.L. MDA7: A novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models. Br J Pharmacol 155 (2008) 1104-1116
19. Nail L.M. Long-term persistence of symptoms. Semin Oncol Nurs 17 (2001) 249-254
20. Ong E.C. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes. Oncology 74 Suppl 1 (2008) 72-75
21. Paice J.A. Mechanisms and management of neuropathic pain in cancer. J Support Oncol 1 (2003) 107-120
22. Park S.B., Krishnan A.V., Lin C.S., Goldstein D., Friedlander M., and Kiernan M.C. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 15 (2008) 3081-3094
23. Quasthoff S., and Hartung H.P. Chemotherapy-induced peripheral neuropathy. J Neurol 249 (2002) 9-17
24. Rabin A.G., and Anderson E.G. Autotomy following limb denervation: Effects of previous exposure to neurectomy. Pain 21 (1985) 105-115
25. Rao R.D., Michalak J.C., Sloan J.A., Loprinzi C.L., Soori G.S., Nikcevich D.A., Warner D.O., Novotny P., Kutteh L.A., and Wong G.Y. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110 (2007) 2110-2118
26. Read S.J., and Dray A. Osteoarthritic pain: A review of current, theoretical and emerging therapeutics. Expert Opin Investig Drugs 17 (2008) 619-640
27. Scripture C.D., Figg W.D., and Sparreboom A. Peripheral neuropathy induced by Paclitaxel: Recent insights and future perspectives. Curr Neuropharmacol 4 (2006) 165-172
28. Tsavaris N., Kopterides P., Kosmas C., Efthymiou A., Skopelitis H., Dimitrakopoulos A., Pagouni E., Pikazis D., Zis P.V., and Koufos C. Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: A pilot study. Pain Med 9 (2008) 1209-1216
29. Verstappen C.C., Heimans J.J., Hoekman K., and Postma T.J. Neurotoxic complications of chemotherapy in patients with cancer: Clinical signs and optimal management. Drugs 63 (2003) 1549-1563
30. Vigano A., Bruera E., and Suarez-Almazor M.E. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83 (1998) 1244-1250
31. Visovsky C., Meyer R.R., Roller J., and Poppas M. Evaluation and management of peripheral neuropathy in diabetic patients with cancer. Clin J Oncol Nurs 12 (2008) 243-247
32. Wampler M.A., Hamolsky D., Hamel K., Melisko M., and Topp K.S. Case report: Painful peripheral neuropathy following treatment with docetaxel for breast cancer. Clin J Oncol Nurs 9 (2005) 189-193
33. Wolf S., Barton D., Kottschade L., Grothey A., and Loprinzi C. Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. Eur J Cancer 44 (2008) 1507-1515
34. Xiao W., Naso L., and Bennett G.J. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med 9 (2008) 505-517
35. Zeltser R., Beilin B., Zaslansky R., and Seltzer Z. Comparison of autotomy behavior induced in rats by various clinically-used neurectomy methods. Pain 89 (2000) 19-24